| |
| |
|
| Insider
Information: |
Langer Robert |
| Relationship: |
Director |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
23,176,520 |
|
|
Indirect Shares
|
68,091 |
|
|
| Direct
Value |
$55,118,034 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,244,611 |
|
|
| Total
Value |
$55,118,034 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2008-08-08 |
950,022 |
|
0 |
Premium* |
|
|
Echo Therapeutics Inc |
ECTE |
Director |
2009-12-11 |
603,450 |
2004-05-26 |
0 |
Premium* |
|
|
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2013-06-05 |
7,433,628 |
|
0 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-26 |
738,424 |
|
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
10% Owner |
2016-06-21 |
457,603 |
|
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-19 |
326,402 |
|
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
Director |
2022-04-28 |
11,467,664 |
2022-04-28 |
42,396 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2019-10-14 |
0 |
2019-01-14 |
0 |
Premium* |
|
|
Korro Bio |
KRRO |
Director |
2020-11-17 |
214,326 |
2020-11-17 |
25,695 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director |
2020-05-05 |
15,167 |
|
0 |
Premium* |
|
|
Sqz Biotechnologies Co |
SQZ |
10% Owner |
2020-10-29 |
243,987 |
|
0 |
Premium* |
|
|
Seer, Inc. |
SEER |
Director |
2023-06-14 |
725,847 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECTE |
Echo Therapeutics Inc |
Director |
– • – |
2004-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
35,211 |
500,041 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2004-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
37,498 |
976,762 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2005-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
975,762 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2005-06-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,740 |
954,022 |
|
- |
|
| ECTE |
Echo Therapeutics Inc |
Director |
– • – |
2006-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
57,504 |
|
- |
|
| ECTE |
Echo Therapeutics Inc |
Director |
– • – |
2007-01-30 |
4 |
B |
$0.10 |
$25,000 |
D/D |
250,000 |
307,504 |
2.39 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2007-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
970,022 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2008-08-08 |
4 |
S |
$16.81 |
$336,200 |
D/D |
(20,000) |
950,022 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
Director |
– • – |
2009-12-11 |
4 |
A |
$1.28 |
$83,000 |
D/D |
64,844 |
603,450 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-04-13 |
4 |
S |
$2.39 |
$95,982 |
D/D |
(40,160) |
8,056,953 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-04-16 |
4 |
S |
$2.40 |
$383,616 |
D/D |
(159,840) |
7,897,113 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-06-26 |
4 |
S |
$2.42 |
$306,251 |
D/D |
(126,550) |
7,770,563 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-06-27 |
4 |
S |
$2.40 |
$32,280 |
D/D |
(13,450) |
7,757,113 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-06-28 |
4 |
S |
$2.30 |
$34,560 |
D/D |
(15,000) |
7,742,113 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-06-29 |
4 |
S |
$2.31 |
$57,167 |
D/D |
(24,780) |
7,717,333 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2012-07-02 |
4 |
S |
$2.39 |
$48,265 |
D/D |
(20,220) |
7,697,113 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-01-15 |
4 |
S |
$2.47 |
$87,587 |
D/D |
(35,436) |
7,661,677 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-01-16 |
4 |
S |
$2.46 |
$253,523 |
D/D |
(102,874) |
7,558,803 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-01-17 |
4 |
S |
$2.46 |
$129,076 |
D/D |
(52,425) |
7,506,378 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-04-24 |
4 |
AS |
$2.96 |
$7,405 |
D/D |
(2,500) |
7,503,878 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-04-25 |
4 |
AS |
$2.94 |
$7,360 |
D/D |
(2,500) |
7,501,378 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-04-26 |
4 |
AS |
$2.85 |
$7,127 |
D/D |
(2,500) |
7,498,878 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-04-29 |
4 |
AS |
$2.99 |
$7,485 |
D/D |
(2,500) |
7,496,378 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-04-30 |
4 |
AS |
$3.19 |
$7,985 |
D/D |
(2,500) |
7,493,878 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
– – • |
2013-05-01 |
4 |
AS |
$3.17 |
$7,920 |
D/D |
(2,500) |
7,491,378 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
